Cited by 1,524Viral-associated cancers and disordersTransplantation: Methods and OutcomesRenal Transplantation Outcomes and Treatments

The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.

Spectrum of Cancer Risk Among US Solid Organ Transplant Recipients

Open access

Engels, Eric A., Pfeiffer, Ruth M., Fraumeni, Joseph F., Kasiske, Bertram L., Israni, Ajay K., Snyder, Jon J., Wolfe, Robert A., Goodrich, Nathan P., Bayakly, A. Rana, Clarke, Christina A., Copeland, Glenn, Finch, Jack L., Fleissner, Mary Lou, Goodman, Marc T., Kahn, Amy, Koch, Lori, Lynch, Charles F., Madeleine, Margaret M., Pawlish, Karen, Rao, Chandrika, Williams, Melanie A., Castenson, David, Curry, Michael, Parsons, Ruth, Fant, Gregory, Lin, Monica·2011·JAMA

DOI 10.1001/jama.2011.1592PMC PMC3310893

Open this paper in CoChat — free account

Abstract

CONTEXT: Solid organ transplant recipients have elevated cancer risk due to immunosuppression and oncogenic viral infections. Because most prior research has concerned kidney recipients, large studies that include recipients of differing organs can inform cancer etiology. OBJECTIVE: To describe the overall pattern of cancer following solid organ transplantation. DESIGN, SETTING, AND PARTICIPANTS: Cohort study using linked data on solid organ transplant recipients from the US Scientific Registry of Transplant Recipients (1987-2008) and 13 state and regional cancer registries. MAIN OUTCOME MEASURES: Standardized incidence ratios (SIRs) and excess absolute risks (EARs) assessing relative and absolute cancer risk in transplant recipients compared with the general population. RESULTS: The registry linkages yielded data on 175,732 solid organ transplants (58.4% for kidney, 21.6% for liver, 10.0% for heart, and 4.0% for lung). The overall cancer risk was elevated with 10,656 cases and an incidence of 1375 per 100,000 person-years (SIR, 2.10 [95% CI, 2.06-2.14]; EAR, 719.3 [95% CI, 693.3-745.6] per 100,000 person-years). Risk was increased for 32 different malignancies, some related to known infections (eg, anal cancer, Kaposi sarcoma) and others unrelated (eg, melanoma, thyroid and lip cancers). The most common malignancies with elevated risk were non-Hodgkin lymphoma (n = 1504; incidence: 194.0 per 100,000 person-years; SIR, 7.54 [95% CI, 7.17-7.93]; EAR, 168.3 [95% CI, 158.6-178.4] per 100,000 person-years) and cancers of the lung (n = 1344; incidence: 173.4 per 100,000 person-years; SIR, 1.97 [95% CI, 1.86-2.08]; EAR, 85.3 [95% CI, 76.2-94.8] per 100,000 person-years), liver (n = 930; incidence: 120.0 per 100,000 person-years; SIR, 11.56 [95% CI, 10.83-12.33]; EAR, 109.6 [95% CI, 102.0-117.6] per 100,000 person-years), and kidney (n = 752; incidence: 97.0 per 100,000 person-years; SIR, 4.65 [95% CI, 4.32-4.99]; EAR, 76.1 [95% CI, 69.3-83.3] per 100,000 person-years). Lung cancer risk was most elevated in lung recipients (SIR, 6.13 [95% CI, 5.18-7.21]) but also increased among other recipients (kidney: SIR, 1.46 [95% CI, 1.34-1.59]; liver: SIR, 1.95 [95% CI, 1.74-2.19]; and heart: SIR, 2.67 [95% CI, 2.40-2.95]). Liver cancer risk was elevated only among liver recipients (SIR, 43.83 [95% CI, 40.90-46.91]), who manifested exceptional risk in the first 6 months (SIR, 508.97 [95% CI, 474.16-545.66]) and a 2-fold excess risk for 10 to 15 years thereafter (SIR, 2.22 [95% CI, 1.57-3.04]). Among kidney recipients, kidney cancer risk was elevated (SIR, 6.66 [95% CI, 6.12-7.23]) and bimodal in onset time. Kidney cancer risk also was increased in liver recipients (SIR, 1.80 [95% CI, 1.40-2.29]) and heart recipients (SIR, 2.90 [95% CI, 2.32-3.59]). CONCLUSION: Compared with the general population, recipients of a kidney, liver, heart, or lung transplant have an increased risk for diverse infection-related and unrelated cancers.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1001/jama.2011.1592

Cites

43 of 43 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues
Swerdlow, S. H. (2017) · Medical Entomology and Zoology · Cited by 12,933
Preoperative assessment of liver function: a comparison of 99mTc‐Mebrofenin scintigraphy with indocyanine green clearance test
Erdogan, D., Heijnen, B. H. M., Bennink, R. J., Kok, M., Dinant, S., Straatsburg, I. H., Gouma, D. J., & van Gulik, T. M. (2004) · Liver International · doi:10.1111/j.1478-3231.2004.00901.x · Cited by 11,656
Liver Transplantation for the Treatment of Small Hepatocellular Carcinomas in Patients with Cirrhosis
Mazzaferro, V., Regalia, E., Doci, R., Andreola, S. A., Pulvirenti, A., Bozzetti, F., Montalto, F., Ammatuna, M., Morabito, A., & Gennari, L. (1996) · New England Journal of Medicine · doi:10.1056/nejm199603143341104 · Cited by 7,173
Acute Abdomen: A Rare Case of Ruptured Hepatocellular Carcinoma
Gloor, S., Jensen, K. O., Breitenstein, S., Binkert, C. A., Angst, E., & Hetzer, F. H. (2017) · Case Reports in Gastroenterology · doi:10.1159/000463378 · Cited by 5,370
Statistical Methods in Cancer Research. Volume II – The Design and Analysis of Cohort Studies
Juul, S. (1989) · Scandinavian Journal of Social Medicine · doi:10.1177/140349488901700214 · Cited by 3,602
A review of human carcinogens—Part B: biological agents
Bouvard, V., Baan, R., Straif, K., Grosse, Y., Secretan, B., Ghissassi, F. E., Benbrahim-Tallaa, L., Guha, N., Freeman, C., Galichet, L., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70096-8 · Cited by 2,935
Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis
Grulich, A. E., van Leeuwen, M. T., Falster, M. O., & Vajdic, C. M. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61050-2 · Cited by 2,321
Statistical methods in cancer research. Volume II--The design and analysis of cohort studies.
Breslow, N. E., & Day, N. E. (1987) · PubMed · Cited by 1,684
Overdiagnosis in Cancer
Welch, H. G., & Black, W. C. (2010) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djq099 · Cited by 1,627
The design and analysis of cohort studies
Breslow, N. E., & Day, N. E. (1987) · International Agency for Research on Cancer eBooks · Cited by 1,312

Flagged first, then by citations

Show all 43 references

Sorted by citations

Items 901–1,000 of 1,000

Simultaneous metastasis of melanoma and lung adenocarcinoma to hilar lymph nodes and pleural effusion after renal transplantation
Tse, J. Y., Stover, D. G., & Chebib, I. A. (2013) · Cytopathology · doi:10.1111/cyt.12088 · Cited by 4
Melanoma Incidence and Lethality Is Increased Following Solid Organ Transplantation
Whiteman, D. C., & Olsen, C. M. (2015) · Journal of Investigative Dermatology · doi:10.1038/jid.2015.326 · Cited by 4
Atypical Marginal Zone Hyperplasia is a Mimic for Lymphoma in Pediatric Transplant Recipients: Report of Two Patients
Caltharp, S. A., Qayed, M. D., & Park, S. I. (2015) · Pediatric and Developmental Pathology · doi:10.2350/15-01-1596-cr.1 · Cited by 4
Immune cell infiltration and inflammatory biomarkers in colorectal cancer
Väyrynen, J. P. (2014) · Cited by 4
Utility of mammography for chronic kidney disease patients undergoing kidney transplant evaluation
Stoecker, J. B., Cote, D. R., Augustine, J. J., Sarabu, N., Schulak, J. A., Sanchez, E. Q., Humphreville, V. R., Ammori, J. B., & Woodside, K. J. (2016) · Clinical Transplantation · doi:10.1111/ctr.12709 · Cited by 4
Management of Anal Cancer
Karanjawala, B. E., & Chang, G. J. (2015) · Springer eBooks · doi:10.1007/978-1-4471-4258-4_51 · Cited by 4
Low Incidence of Malignancy After Heart Transplantation in Taiwan
Wang, Y.-J., Chi, N., Chou, N., Huang, S.-J., Wang, C., Wu, I., Yu, H., Chen, Y., Tsao, C.-I., Shun, C., et al. (2016) · Transplantation Proceedings · doi:10.1016/j.transproceed.2015.12.079 · Cited by 4
Perioperative management of esophagectomy in a patient who previously underwent bilateral lung transplantation
Toyama, H., Saito, K., Takei, Y., Saito, K., Fujimine, T., Ejima, Y., Kamei, T., Watanabe, T., Okada, Y., & Yamauchi, M. (2016) · JA Clinical Reports · doi:10.1186/s40981-016-0041-x · Cited by 4
Prostate Cancer Metastatic to the Renal Allograft: A Case Report
Alaini, A., Singh, P., Shah, R., Fischer, E. G., Ganta, K., Barrett, T., & Servilla, K. S. (2017) · Transplantation Proceedings · doi:10.1016/j.transproceed.2016.11.031 · Cited by 4
Iatrogenic solid tumors following immunosuppressive therapy
Dantey, K. E., & Pantanowitz, L. (2017) · Seminars in Diagnostic Pathology · doi:10.1053/j.semdp.2017.09.002 · Cited by 4
Reassessing risks and benefits of living kidney donors with a history of thyroid cancer
Adler, J. T., Yeh, H., Barbesino, G., & Lubitz, C. C. (2017) · Clinical Transplantation · doi:10.1111/ctr.13114 · Cited by 4
Comparative transcriptome analysis of peripheral blood mononuclear cells in renal transplant recipients in everolimus- and tacrolimus-based immunosuppressive therapy
Granata, S., Santoro, G., Signorini, L. F., Malerba, G., Patuzzo, C., Gambaro, G., Stallone, G., & Zaza, G. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.172494 · Cited by 4
Outcome of Colonoscopic Screening in Potential Liver Transplant Candidates
Sakr, M., Ebada, H. E., Abdel-Kader, S., Dabbous, H. M., Montasser, I. F., Bassuny, A. N., Massoud, Y. M., & Abdelmoaty, A. S. (2020) · Transplantation Proceedings · doi:10.1016/j.transproceed.2019.10.026 · Cited by 4
Anaplastic large cell lymphoma in human immunodeficiency virus‐infected people and solid organ transplant recipients
Mahale, P. S., Weisenburger, D. D., Kahn, A. R., Gonsalves, L., Pawlish, K. S., Koch, L., Tírado-Gómez, M., Clarke, C. A., Alverson, G., Shiels, M. S., et al. (2020) · British Journal of Haematology · doi:10.1111/bjh.16778 · Cited by 4
Self-citation
De novo colorectal cancer after liver and kidney transplantation–Microenvironment disturbance
Oliveira, R. C., Tavares-da-Silva, E., Abrantes, A. M., Antunes, H., Teixeira, P., Gomes, A., Martins, R. J. T., Furtado, E., Figueiredo, A., Costa, B. P., et al. (2020) · Transplantation Reports · doi:10.1016/j.tpr.2020.100057 · Cited by 4
Treatment and Outcomes of Early Stage Breast Cancer in Patients with Hepatic Dysfunction
Olimpiadi, Y. B., Brownson, K. E., Kahn, J. A., Kim, B. S., Han, H. H., Khemichian, S., Fong, T., Kang, I. M., Terando, A. M., & Lang, J. E. (2020) · Journal of Surgical Research · doi:10.1016/j.jss.2020.06.022 · Cited by 4
Endometrial cancer in a renal transplant recipient: A case report
Liu, N., Yang, L., Yan, L., & Jiang, G. (2020) · Open Medicine · doi:10.1515/med-2020-0118 · Cited by 4
FDG PET/CT for Detection of Infectious Complications Following Solid Organ Transplantation
Wareham, N. E., Nielsen, S. D., Sørensen, S. S., & Fischer, B. M. (2021) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2020.12.007 · Cited by 5
Prior antithymocyte globulin therapy and survival in post-transplant lymphoproliferative disorders
Kinch, A., Baecklund, E., Molin, D., Pauksens, K., Sundström, C., Tufveson, G., & Enblad, G. (2021) · Acta Oncologica · doi:10.1080/0284186x.2021.1904520 · Cited by 4
Drug interaction profile of TKI alectinib allows effective and safe treatment of ALK+ lung cancer in the kidney transplant recipient
Bilek, O., Holánek, M., Juřica, J., Štěpánková, S., Vašina, J., Selingerová, I., Poprach, A., Bořilová, S., Kazda, T., Kišš, I., et al. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.108012 · Cited by 4
Life‐years lost due to cancer among solid organ transplant recipients in the United States, 1987 to 2014
Noone, A., Pfeiffer, R. M., Schaubel, D. E., Dorgan, J. F., Magder, L. S., Bromberg, J. S., Lynch, C. F., Morris, C. R., Pawlish, K. S., & Engels, E. A. (2021) · Cancer · doi:10.1002/cncr.33877 · Cited by 4
Self-citation
A Reduction of Calcineurin Inhibitors May Improve Survival in Patients with De Novo Colorectal Cancer after Liver Transplantation
Saidy, R. R. O., Wegener, E., Uluk, D., Dittrich, L. S., Schöning, W., Lurje, G., Öllinger, R., Modest, D. P., Tacke, F., Haase, O., et al. (2022) · Medicina · doi:10.3390/medicina58121755 · Cited by 4
New Hydronephrosis in the Native Kidney Is Associated with the Development of De Novo Urinary Bladder Urothelial Carcinoma in Patients with Post-Kidney Transplantation
Ho, C.-J., Huang, Y.-H., Hsieh, T.-Y., Yang, M.-H., Wang, S., Chen, W.-J., Sung, W., & Chen, S. (2023) · Healthcare · doi:10.3390/healthcare11091209 · Cited by 4
Impact of newly diagnosed prostate cancer at time of evaluation for renal transplantation
Poinard, F., Bessède, T., Barrou, B., Drouin, S., Karam, G., Branchereau, J., Alezra, E., Thuret, R., Verhoest, G., goujon, A., et al. (2023) · Clinical Transplantation · doi:10.1111/ctr.14998 · Cited by 4
Cancer Risk Following HLA-Incompatible Living Donor Kidney Transplantation
Motter, J. D., Massie, A. B., Garonzik‐Wang, J., Pfeiffer, R. M., Yu, K. J., Segev, D. L., & Engels, E. A. (2023) · Transplantation Direct · doi:10.1097/txd.0000000000001505 · Cited by 4
Self-citation
Post-transplant malignancy: Focusing on virus-associated etiologies, pathogenesis, evidence-based management algorithms, present status of adoptive immunotherapy and future directions
Yadav, R., Kossi, M. E., Belal, D., Sharma, A., & Halawa, A. (2023) · World Journal of Meta-Analysis · doi:10.13105/wjma.v11.i7.317 · Cited by 4
Barriers toward xenotransplantation in Arab World
Ghazi, M., Saleh, A. A., Abdallah, M., Masri, D. E., Masri, J. E., Ayoubi, L. M. E., Hawi, J. S., & Jurjus, A. R. (2024) · Xenotransplantation · doi:10.1111/xen.12852 · Cited by 4
Surveillance and management of de novo malignancy after liver transplantation
Kang, W. (2024) · Annals of Liver Transplantation · doi:10.52604/alt.24.0006 · Cited by 4
Tepotinib in a Patient With Advanced Non-Small Cell Lung Cancer Harboring MET Exon 14 Skipping Undergoing Concomitant Hemodialysis for Renal Failure: A Case Report
Kleemiss, M., Müller, C. E., Schneider, M., Strotmann, R., Orlowski, K., Goteti, K., Yanik, M., Brossart, P., & Bauernfeind, F. (2024) · Clinical Lung Cancer · doi:10.1016/j.cllc.2024.05.008 · Cited by 4
Case Report: Spontaneous Hemorrhage of a Rare Renal Tumor in the Native Kidney of a Renal Transplant Recipient
Tan, A., Lawson, M., Preston, J. M., Wood, S., Griffin, A., & Rhee, H. (2018) · Transplantation Proceedings · doi:10.1016/j.transproceed.2017.11.031 · Cited by 4
Interaction Between Cyclosporine and Palbociclib in a Renal Transplant Patient: Case Report and Pharmacokinetic Perspective
Momper, J. D., Yang, J. Y., Kerr, J., Saunders, I. M., Smith, J., & Shah, M. M. (2019) · Journal of Pharmacy Practice · doi:10.1177/0897190019851887 · Cited by 4
Treatment of Multiple Myeloma With Daratumumab in a Kidney Transplant Patient
Yang, D., Agrawal, N., Marcus, C. B., Roy, N., Richards, K. R., Nahas, M. R., & Cardarelli, F. (2019) · American Journal of Therapeutics · doi:10.1097/mjt.0000000000001024 · Cited by 4
Chronic myeloid leukemia in solid organ transplant patients: a case series
Amitai, I., Abulafia, A. S., Raanani, P., & Lipton, J. H. (2020) · International Journal of Hematology · doi:10.1007/s12185-020-03014-5 · Cited by 4
A 3-Decade Analysis of Pancreatic Adenocarcinoma After Solid Organ Transplant
Corral, J. E., Croome, K. P., Keaveny, A. P., Brahmbhatt, B. S., Kröner, P. T., Wijarnpreecha, K., GOSWAMI, R. M., Raimondo, M., Wallace, M. B., Bi, Y., et al. (2020) · Pancreas · doi:10.1097/mpa.0000000000001722 · Cited by 4
Update on B-cell lymphoproliferative disorders of the gastrointestinal tract
Plummer, R. M., Linden, M. A., & Beckman, A. K. (2021) · Seminars in Diagnostic Pathology · doi:10.1053/j.semdp.2021.03.006 · Cited by 4
Tumor Recurrence and Graft Survival in Renal Transplant Recipients with a History of Pretransplant Malignancy: A Matched Pair Analysis
Becker, F., Mehdorn, A., Getsopulos, V., Schütte‐Nütgen, K., Reuter, S., Suwelack, B. M., Pascher, A., Brockmann, J. G., & Bahde, R. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10112349 · Cited by 4
Interactions between human microbiome, liver diseases, and immunosuppression after liver transplant
Peruhova, M., Peshevska-Sekulovska, M., & Velikova, T. V. (2021) · World Journal of Immunology · doi:10.5411/wji.v11.i2.11 · Cited by 4
Update: Solar UV Radiation, Vitamin D, and Skin Cancer Surveillance in Organ Transplant Recipients (OTRs)
Saternus, R., VOGT, T. M., & Reichrath, J. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-46227-7_17 · Cited by 4
Analysis of clinicopathological features of papillary thyroid carcinoma in solid organ transplant recipients: a retrospective study
Hu, L., Wu, Y., Ju, F., Zhang, Y., & Wang, W. (2022) · Gland Surgery · doi:10.21037/gs-22-431 · Cited by 4
The transplant patient and transplant medicine in family practice
Hughes, L. (2014) · Journal of Family Medicine and Primary Care · doi:10.4103/2249-4863.148106 · Cited by 4
Case Report: Combined Small Cell Lung Cancer in a Lung Transplant Recipient
Moniodis, A., Racila, E. V., & Divo, M. J. (2015) · Transplantation Proceedings · doi:10.1016/j.transproceed.2015.01.019 · Cited by 4
Allogeneic Hematopoietic Cell Transplantation for Therapy-Related Myeloid Leukemia following Orthotopic Cardiac Transplantation
Lin, R. J., Larson, R. A., van Besien, K., & Rich, E. S. (2013) · Case Reports in Hematology · doi:10.1155/2013/140138 · Cited by 4
Neoadjuvant chemotherapy and radical radiotherapy associated with cetuximab for laryngeal cancer in a pancreas and renal recipient
Bonetta, A., Bandera, L., Roviello, G., Cafaro, I., Bottini, A., & Generali, D. (2016) · Anti-Cancer Drugs · doi:10.1097/cad.0000000000000352 · Cited by 4
Renal Tumor in Allogeneic Kidney Transplant Recipient
Bieniasz, M., Chmura, A., Kwapisz, M., Czerwińska, M., Kieszek, R., Domagała, P., Wszola, M., Serwańska-Świętek, M., Górnicka, B., Durlik, M., et al. (2016) · Transplantation Proceedings · doi:10.1016/j.transproceed.2016.01.051 · Cited by 4
m-TOR inhibitor as potential radiosensitizer for head and neck squamous cell carcinoma: A case report of an organ transplant patient and review of the literature
Daste, A., de Monès, E., Dupin, C. L., François, L., Ravaud, A., & Digue, L. (2016) · Oral Oncology · doi:10.1016/j.oraloncology.2016.08.008 · Cited by 4
Cancer risk following post‐transplant lymphoproliferative disorders in solid organ transplant recipients
Mahale, P. S., Engels, E. A., Lynch, C. F., & Morton, L. M. (2019) · British Journal of Haematology · doi:10.1111/bjh.15828 · Cited by 4
Self-citation
A Call to Action: The Need for Improved Transplant Cancer Screening Guidelines
Blosser, C. D. (2016) · American Journal of Transplantation · doi:10.1111/ajt.14034 · Cited by 4
Dermatoses of the Oral Cavity and Lips
Scully, C. M. (2016) · Wiley eBooks · doi:10.1002/9781118441213.rtd0111 · Cited by 4
Allogeneic Hematopoietic Stem Cell Transplantation After Solid Organ Transplantation in Patients With Hematologic Malignancies Managed With Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis
Jang, C., & Hsu, J. (2024) · Journal of Hematology · doi:10.14740/jh1327 · Cited by 3
High torque Teno virus load is associated with increased all-cause mortality risk in liver transplant recipients: a multicenter cohort study
Akdag, D., Rostved, A. A., Kirkby, N. S., Rasmussen, A., Lassen, U., Andersen, C. L., Ericzon, B., Jorns, C., Zhao, H., Bennet, W., et al. (2025) · Transplant Immunology · doi:10.1016/j.trim.2025.102309 · Cited by 3
Acceptance of HPV Vaccination in Kidney Transplant Recipients
Hebert, S. A., Golovine, A. M. D., Swinford, R. D., Bell, C., Vigil, K. J., & Bhatnagar, S. (2018) · OBM Transplantation · doi:10.21926/obm.transplant.1803017 · Cited by 3
Variations in Risk of Cancer and Death From Cancer According to Kidney Allograft Function, Graft Loss, and Return to Dialysis
Au, E. H. K., Chapman, J. R., Teixeira-Pinto, A. M., Craig, J. C., & Wong, G. (2023) · Transplantation · doi:10.1097/tp.0000000000004493 · Cited by 3
Sleep and quality of life in kidney transplant recipients with and without non-melanoma skin cancer: a comparative study
Xerfan, E. M. S., Leandro, G., Pires, G. N., Andersen, M. L., Tufik, S. B., Facina, A. S., & Tomimori, J. (2023) · Archives of Dermatological Research · doi:10.1007/s00403-023-02735-x · Cited by 3
Rapidly progressive interstitial lung disease with positive anti-MDA5 antibody as an immune-related complication of nivolumab: A case report
Kato, S., Sakamoto, K., Sato, T., Kobayashi, T., Shindo, Y., Morise, M., Iwama, S., Arima, H., & Ishii, M. (2024) · Respiratory Investigation · doi:10.1016/j.resinv.2024.01.009 · Cited by 3
Incidence and clearance of cervical and anal high-risk human papillomavirus in kidney transplant recipients: Results from a Danish prospective clinical study
Ring, L. L., Larsen, H. K., Frederiksen, K., Hædersdal, M., Sørensen, S. S., Bonde, J. H., Thomsen, L. T., & Kjær, S. K. (2024) · American Journal of Transplantation · doi:10.1016/j.ajt.2024.03.005 · Cited by 3
The pre‐transplant evaluation: Considerations for trainees and early career transplant infectious diseases clinician
Kumar, R. N., Gorsline, C. A., Rader, T. S., Boucher, H. W., Malinis, M. F., Koff, A., & Harris, C. E. (2024) · Transplant Infectious Disease · doi:10.1111/tid.14326 · Cited by 3
Prostate cancer in solid organ transplant recipients: Results from a multicenter series
Hedhli, O., Marra, G., Georges, K., Glemain, P., Chelghaf, I., Vergie, S. D., Perrouin‐Verbe, M., Luigi, B., Paolo, G., Bouchot, O., et al. (2024) · The French Journal of Urology · doi:10.1016/j.fjurol.2024.102841 · Cited by 3
Liver transplantation for cirrhosis and its complications
Grossar, L., & Verhelst, X. (2024) · Acta Clinica Belgica · doi:10.1080/17843286.2025.2456183 · Cited by 3
Oncological Complications of Liver Transplantation: A Narrative Review on De Novo and Donor-Transmitted Cancers
Cavoli, T. V. L., Curto, A., Lynch, E. N., & Galli, A. (2025) · Transplantology · doi:10.3390/transplantology6020015 · Cited by 4
Malignancies After Renal Transplantation: Frequency, Etiology, and Prognosis—A Single Center Experience
Atalah, F., Acarbay, A., Karakök, A., Beşiroğlu, M., Kuş, F., Arıcı, H., Dirim, A. B., Süleymanova, V., Türkmen, A., & Yazıcı, H. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14165858 · Cited by 3
Risk of deficient mismatch repair colorectal cancer and precursors after kidney transplantation: A nationwide study
Zwart, K., van Kruijsdijk, R. C. M., Angerilli, V., Baas, M. C., Dekker, E., Rutgers, N., May, A. M., Koopman, M., Nagtegaal, I. D., & Bol, G. M. (2025) · American Journal of Transplantation · doi:10.1016/j.ajt.2025.11.001 · Cited by 3
Tumoren nach Nierentransplantation
Opgenoorth, M., & Hugo, C. (2013) · Der Onkologe · doi:10.1007/s00761-013-2430-3 · Cited by 3
Immuno-oncology of Dormant Tumours
Nabavi, N., Roberts, M. E., Crea, F., Collins, C. C., Wang, Y. Z., & Bishop, J. L. (2017) · Cancer drug discovery and develogment/Cancer drug discovery and development · doi:10.1007/978-3-319-59242-8_4 · Cited by 3
Screening Mammography Findings in Women With Chronic Kidney Disease on a Renal Transplant Waiting List
Voyvoda, N., Voyvoda, B., & Özer, T. (2019) · Clinical Breast Cancer · doi:10.1016/j.clbc.2019.01.009 · Cited by 3
Robot assisted laparoscopic prostatectomy in liver transplant recipient
Lim, K., Riccardo Autorino, B., Veccia, A., Zukovksi, E. B., Levy, M. F., & Hampton, L. J. (2019) · Minerva Urologica e Nefrologica · doi:10.23736/s0393-2249.19.03334-4 · Cited by 3
Colorectal Cancer Prevention in Lung Transplant Recipients: The Need for an Enhanced Surveillance Protocol
Dameworth, J. L., Colburn, L., Corrigan, D. C., Driessen, R., Chapple, K. M., Gagliano, R. A., Walia, R., & Row, D. (2021) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2020.12.053 · Cited by 3
Malignancy post-hematopoietic stem cell transplant in patients with primary immunodeficiency
Lum, S. H., & Slatter, M. A. (2020) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2020.1763792 · Cited by 3
Over-diagnosed prostate cancer in solid organ recipients: lessons from the last 3 decades
Waeckel, T., Said, K. A., Altieri, M. H., Belin, A., Doerfler, A., & Tillou, X. (2020) · International Urology and Nephrology · doi:10.1007/s11255-020-02636-2 · Cited by 3
Renal cell carcinoma in native nephrectomy specimens of autosomal dominant polycystic kidney disease (ADPKD) patients with end-stage renal disease: Findings from an Australian transplant center
Mansbridge, M. M., Lawson, M., Preston, J. M., Griffin, A., Wood, S., & Rhee, H. (2021) · Journal of Clinical Urology · doi:10.1177/20514158211010653 · Cited by 3
Rapid progression of colonic mucinous adenocarcinoma with immunosuppressive condition: A case report and review of literature
Koseki, Y., Kamimura, K., Tanaka, Y., Ohkoshi-Yamada, M., Zhou, Q., Matsumoto, Y., Mizusawa, T., Sato, H., Sakamaki, A., Umezu, H., et al. (2021) · World Journal of Clinical Cases · doi:10.12998/wjcc.v9.i30.9182 · Cited by 3
Increased Expressions of Programmed Death Ligand 1 and Galectin 9 in Transplant Recipients Who Achieved Tolerance After Immunosuppression Withdrawal
Nam, N. H., Taura, K., Koyama, Y., Nishio, T., Yamamoto, G., Uemoto, Y., Kimura, Y., Xuefeng, L., Nakamura, D., Yoshino, K., et al. (2021) · Liver Transplantation · doi:10.1002/lt.26336 · Cited by 3
Immunotherapy and Antivascular Targeted Therapy in Patients’ Treatment with Concurrent Malignant Tumors after Organ Transplantation: Opportunity or Challenge
Shen, B., Guo, Z., Huang, P., Tan, M., Zhang, X., Lin, S., Song, C., Wang, J., & Huang, M. (2022) · Journal of Immunology Research · doi:10.1155/2022/6440419 · Cited by 3
The role of radiology in addressing the challenge of lung cancer after lung transplantation
Delaney, F. T., Murray, J. G., Hutchinson, B. D., Egan, J. J., Murray, M., Winward, S., Ronan, N. J., & Cronin, C. G. (2022) · European Radiology · doi:10.1007/s00330-022-08942-w · Cited by 3
Treatment patterns and survival of low and intermediate‐risk prostate cancer in end‐stage kidney disease: A retrospective population cohort study
Sarabu, N., Dong, W., Ray, A. W., Fernstrum, A. J., Prunty, M. C., Ponsky, L. E., Shoag, J. E., Shahinian, V. B., Lentine, K. L., & Koroukian, S. M. (2023) · Cancer Medicine · doi:10.1002/cam4.5571 · Cited by 3
How to Estimate the Probability of Tolerance Long-Term in Liver Transplant Recipients
Eurich, D., Schlickeiser, S., Saidy, R. R. O., Uluk, D., Roßner, F., Postel, M. P., Schoening, W. N., Oellinger, R., Lurje, G., Pratschke, J., et al. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12206546 · Cited by 3
Mapping of Human Polyomavirus in Renal Cell Carcinoma Tissues
Mobaraki, G., Shi, S., Liu, D., Smits, K. M., Severens, K., Lommen, K., Rennspiess, D., Speel, E. M., Winnepenninckx, V. J. L., Klufah, F., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25158213 · Cited by 3
A Case of Rapidly Progressing Urothelial Carcinoma Arising After Living Donor Kidney Transplantation Treated with Chemotherapy and Immune Checkpoint Inhibitors
Hikita, K., Nishikawa, R., Taniguchi, S., Mae, Y., Iyama, T., Takata, T., Morizane, S., Honda, M., & Takenaka, A. (2025) · Yonago acta medica · doi:10.33160/yam.2025.02.009 · Cited by 3
Incidence, screening, and management of de novo malignancies in liver transplant patients: A review
Singh, A., Singh, C. M., Dhaliwal, A. S., Singh, N., Kumar, V., Sohal, A., & Schneider, J. A. (2025) · World Journal of Transplantation · doi:10.5500/wjt.v15.i3.101046 · Cited by 3
Upper Aerodigestive Tract Cancer in Patients With Chronic Lymphocytic Leukemia
Pagedar, N. A., Halfdanarson, T. R., Karnell, L. H., Hoffman, H. T., & Funk, G. F. (2012) · Archives of Otolaryngology - Head and Neck Surgery · doi:10.1001/jamaoto.2013.723 · Cited by 3
Technical aspects involved in the harvesting and preservation of the pancreas used for pancreatic islet allotransplantation.
Romanescu, D., Gangone, E., Boeți, M. P. S., Zamfir, R., Dima, S., & Popescu, I. (2013) · PubMed · Cited by 3
Posttransplant Malignancies in Adult Renal and Hepatic Transplant Patients
Rahatlı, S., Altundağ, Ö., Soy, E. H. A., Moray, G., & Haberal, M. A. (2018) · Experimental and Clinical Transplantation · doi:10.6002/ect.2018.0177 · Cited by 3
Renal transplant recipients suffer significantly more complications but not mortality after breast cancer surgery and benefit from treatment at transplant centers
Choubey, A. P., Parsikia, A., Dubchuk, C., Castaldi, M. T., Latifi, R., & Ortiz, J. A. (2021) · Annals of Breast Surgery · doi:10.21037/abs-20-56 · Cited by 3
Foremost Concepts in Mechanisms of De Novo Post-Liver Transplantation Malignancy
Peruhova, M., Peshevska-Sekulovska, M., Panayotova, G. G., & Velikova, T. V. (2021) · Gastroenterology Insights · doi:10.3390/gastroent12030025 · Cited by 3
Liver transplantation-associated lung cancer in smokers: Results of an early CT detection program
Lantuejoul, L. R., Toffart, A., Ghelfi, J., Decaens, T., Hilleret, M., Brichon, P. Y., Stephanov, O., Jankowski, A., Reymond, É., & Ferretti, G. (2021) · Journal of Liver Transplantation · doi:10.1016/j.liver.2021.100050 · Cited by 3
Diagnosis, treatment, and outcome of primary CNS lymphoma—a single-center experience
Wismann, J., Sommer-Sørensen, R. H., Kofoed, M. S., Halle, B., Pedersen, C. B., Schulz, M. K., Grønhøj, M. H., Larsen, T. S., Møller, M. B., & Poulsen, F. R. (2022) · Acta Neurochirurgica · doi:10.1007/s00701-022-05170-5 · Cited by 3
Global research productivity of post-transplant lymphoproliferative disorder: a bibliometric study
Rawashdeh, B., AlRyalat, S. A., Rawshdeh, A., Abuassi, M. A., Al‐Mansour, Z., & El‐Hinnawi, A. (2024) · Annals of Medicine and Surgery · doi:10.1097/ms9.0000000000001771 · Cited by 3
Grafted Sertoli Cells Exert Immunomodulatory Non-Immunosuppressive Effects in Preclinical Models of Infection and Cancer
Chiappalupi, S., Salvadori, L., Borghi, M., Mancuso, F., Pariano, M., Riuzzi, F., Luca, G., Romani, L. R., Arato, I., & Sorci, G. (2024) · Cells · doi:10.3390/cells13060544 · Cited by 3
Medication Exposures and Subsequent Development of Ewing Sarcoma: A Review of FDA Adverse Event Reports
Cope, J. U., Reaman, G. H., & Tonning, J. M. (2015) · Sarcoma · doi:10.1155/2015/948159 · Cited by 3
Icotinib combined with rapamycin in a renal transplant recipient with epidermal growth factor receptor-mutated non-small cell lung cancer: A case report
Zhao, Q., Wang, Y., Tang, Y., & Peng, L. (2013) · Oncology Letters · doi:10.3892/ol.2013.1657 · Cited by 3
Targeted Cancer Screening After Solid-Organ Transplantation
Schmid, M., Chun, F. K. ‐., & Trinh, Q. (2016) · JAMA Oncology · doi:10.1001/jamaoncol.2015.5172 · Cited by 3
Kidney transplantation in patients with history of malignancy Time to rethink the guidelines
Sloan, J. M. (2015) · Frontiers in Bioscience-Elite · doi:10.2741/745 · Cited by 3
Survival after subsequent non-Hodgkin’s lymphoma and non-small cell lung cancer in patients with malignant thymoma
Parzen, J. S., Bates, J. E., Milano, M. T., & Dhakal, S. (2016) · Journal of Thoracic Disease · doi:10.21037/jtd.2016.12.59 · Cited by 3
Post-transplant Lymphoproliferative Disorder of Naso-orbital Region in Adult Renal Transplant Recipients: A Case Report and Literature Review
Nimitpanya, P., Limpanavongsaen, P., Udomkarnjananun, S., Jutivorakool, K., & Vanichanan, J. (2020) · Transplantation Proceedings · doi:10.1016/j.transproceed.2020.01.047 · Cited by 3
Results of Renal Transplantation
Patzer, R. E., & Knechtle, S. J. (2014) · Elsevier eBooks · doi:10.1016/b978-1-4557-4096-3.00039-8 · Cited by 3
Heart transplantation in patients with localized prostate cancer—Are we denying a life‐saving therapy due to an indolent tumor?
Raikhelkar, J., Pham, M., Lourenço, L. M., Narang, N., Chung, B., Nguyen, A. B., Kim, G. H., SAYER, G. T., & Uriel, N. Y. (2020) · Clinical Transplantation · doi:10.1111/ctr.14080 · Cited by 3
Increased Risk of Advanced Colonic Adenomas and Timing of Surveillance Colonoscopy Following Solid Organ Transplantation
Ashkar, M. H., Chen, J. M., Shy, C., Crippin, J. S., Chen, C.-H., Sayuk, G. S., & Davidson, N. O. (2021) · Digestive Diseases and Sciences · doi:10.1007/s10620-021-06987-3 · Cited by 3
Simultaneous pancreas-kidney transplantation
Mosca, I., Sharples, E. J., Sinha, S., & Friend, P. J. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814833-4.00012-5 · Cited by 3
Primary and Secondary Sclerosing Cholangitis
Bowlus, C. L., Assis, D. N., & Goldberg, D. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-37591-7.00043-4 · Cited by 3
Concomitant Simple Limbal Epithelial Transplantation After Surgical Excision of Ocular Surface Squamous Neoplasia
Guarnieri, A., & Moreno‐Montañés, J. (2017) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2017.04.015 · Cited by 3
Advances in liver transplantation for unresectable colon cancer liver metastasis
Cui, X., Geng, X., Zhou, D., Yang, M., & Hou, H. Y. (2021) · World Journal of Gastrointestinal Surgery · doi:10.4240/wjgs.v13.i12.1615 · Cited by 2

Authors: Engels, E. A., Pfeiffer, R. M., Fraumeni, J. F., Kasiske, B. L., Israni, A. K., Snyder, J. J., Wolfe, R. A., Goodrich, N. P., Bayakly, A. R., Clarke, C. A., Copeland, G., Finch, J. L., Fleissner, M. L., Goodman, M. T., Kahn, A., Koch, L., Lynch, C. F., Madeleine, M. M., Pawlish, K., Rao, C., Williams, M. A., Castenson, D., Curry, M., Parsons, R., Fant, G., & Lin, M.
Affiliations: National Institutes of Health (US)
Arbor Research Collaborative for Health (US)
Cancer Prevention Institute of California (US)
Michigan Department of Health and Human Services (US)
Connecticut Agricultural Experiment Station (US)
University of Hawaiʻi at Mānoa (US)
Illinois Department of Public Health (US)
University of Iowa (US)
Fred Hutch Cancer Center (US)
New Jersey Department of Health (US)
Texas Department of State Health Services (US)
Information Management Services (US)
United States Department of Health and Human Services (US)
Corresponding author: Engels, Eric A.
ORCID: Engels, Eric A.
Pfeiffer, Ruth M.
Kasiske, Bertram L.
Israni, Ajay K.
Snyder, Jon J.
Goodrich, Nathan P.
Clarke, Christina A.
Copeland, Glenn
Finch, Jack L.
Goodman, Marc T.
Kahn, Amy
Lynch, Charles F.
Madeleine, Margaret M.
Pawlish, Karen
Rao, Chandrika
Castenson, David
Curry, Michael
Fant, Gregory
Venue: JAMA
Publisher: American Medical Association (AMA)
Published: 2011-11-02
Volume: 306
Issue: 17
Pages: 1891
ISSN: 0002-9955 (ISSN-L)
0098-7484
DOI: 10.1001/jama.2011.1592
PMC: PMC3310893
OpenAlex: W1964106115
Cited by: 1,524
References: 43
Citations by year: 2026: 83 · 2025: 100 · 2024: 100 · 2023: 89 · 2022: 106 · 2021: 114 · 2020: 134 · 2019: 124 · 2018: 107 · 2017: 114 · 2016: 108 · 2015: 106 · 2014: 97 · 2013: 83 · 2012: 55
FWCI: 37.37
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Locations: JAMA (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: National Institutes of Health (n01pc54405-9-0-0, n01pc35143-20-0-1, n01pc35139-25-0-11, n01pc35142-19-0-0, n01pc35137-18-0-2)
National Cancer Institute (N01PC35139, HHSN261201000034 C, HHSN261201000036C, HHSN261201000035C, N01‐PC035137, N01 PC035143, N01 PC35142, HHSN261201000037C, N01-PC-54405, HHSN261201000035I, N01-PC-35 137, N01PC-35143, N01 PC035139, HHSN261201000024C, N01 PC035142, N01 PC054405, ZIACP010150)
National Center for Chronic Disease Prevention and Health Promotion (5U58DP000824-04, 5U58DP000812-03, U58 DP000812, U58 DP000817, U58 DP000805, U58 DP000807, U58 DP000848-04, U58 DP000832, 5U58DP000817-05, U58 DP000824, U58/DP000808, #1U58DP000807-01, 5658DP 000805-04, U58 DP000848, 5U58/DP000808-03)
Topics: Health Sciences › Medicine › Oncology › Viral-associated cancers and disorders
Health Sciences › Medicine › Surgery › Transplantation: Methods and Outcomes
Health Sciences › Medicine › Transplantation › Renal Transplantation Outcomes and Treatments
Keywords: solid organ transplant recipients, cancer risk, immunosuppression, non-Hodgkin lymphoma, lung cancer, Kaposi's sarcoma, anal cancer, melanoma, thyroid cancer, lip cancer, hepatitis C, cytomegalovirus, Epstein-Barr virus, post-transplant lymphoproliferative disorder
MeSH terms: Adolescent, Adult, Aged, Child, Child, Preschool, Female, Humans, Immune Tolerance, Infant, Male, Middle Aged, Neoplasms, Registries, Risk, United States, Cohort Studies, Incidence, Organ Transplantation, Immunocompromised Host, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Spectrum of Cancer Risk Among US Solid Organ Transplant Recipients

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks